Technology Novel Small Molecule Treatment for Staphylococcus Aureus SSTI Infections SUMMARY Staphylococcus aureus infects 50,000 patients and kills 20,000 annually in the United States alone. With widespread antibiotic resistance, there is an urgent need for alternative mechanisms of targeting S.…
News From Discovery to Dissemination: How a New Collaboration is Helping Get Knowledge ‘Out the Door’ Healthcare investment firm Deerfield Management recently visited the University of Chicago to meet with researchers and discuss Hyde Park Discovery, a new collaboration to advance discoveries from the lab. “I’m...
News UChicago Docs Develop Content for New Web App for Physicians Three UChicago physicians (left to right) Adam Cifu, MD, Scott Stern, MD, and Diane Altkorn, MD, developed the content for a new Web app diagnosis tool licensed by startup Agile...
News In Conversation with Polsky Investor-In-Residence Tim Kelly: ‘We Will Evolve and Adapt’ The COVD-19 pandemic is changing the way business is conducted, notes Polsky Center Investor-In-Residence Tim Kelly, MBA ’00, who in this Q&A discusses evolving strategy in times of crisis –...
Technology Nanovaccine That Activates The NLRP3 Inflammasome & Enhances Tumor Specific Activation Of Anti-Cancer Immunity A major attention of vaccine adjuvant development has been focused on development of robust antibody-mediated protection against pathogens. However, such adjuvants have failed to elicit a robust T-cell mediated protection…
Technology Novel Mycobacterial Small Molecules That Bind MR1 And Are Activating Or Antagonistic For MR1-Restricted T cells. TB bacterium, Mycobacterium tuberculosis (M. tuberculosis), is extremely slow growing compared to other bacteria and is naturally resistant to many of the powerful antibiotics that are effective against other bacterial…
News BeeNana Wins First Place at the 2017 College New Venture Challenge The Polsky Center for Entrepreneurship and Innovation at the University of Chicago Booth School of Business is pleased to announce the winners of the 2017 College New Venture Challenge. The Polsky Center’s...
Program Advisors Tim Kelly, MBA ’00 Polsky Center Investor-in-Residence, Consultant to the Svider Private Equity Program Tim Kelly’s private equity career spans nearly three decades, including senior leadership and investment management roles...
News A New Approach to Migraine Therapy University of Chicago researchers are opening a new front in treating migraine that could hold out hope for millions with the painful, debilitating condition—by mimicking the protective effects of physical...
News Innovation Fund Advances Test for Cancer Therapy The primary treatment for breast cancer is either tumor excision followed by radiation or mastectomy with or without radiation therapy. Either course is often followed with chemotherapy. But radiation therapy...
News Davidson Embodies Entrepreneurial Spirit Some Chicago-based researchers with a commercial success or two under their belt head for the East or West Coasts, which are known for nurturing translational research. Michael Davidson, MD, however,...
News fillow, the First All-Female Team to Be Named Winner of the CNVC, Takes Home $75,000 The Polsky Center for Entrepreneurship and Innovation at the University of Chicago is pleased to announce the winners of the 2021 College New Venture Challenge (CNVC). The CNVC is the College track of...
